Many studies have reported that metabolic dysfunction is closely involved in the complex
mechanism underlying the development of non-alcoholic fatty liver disease (NAFLD), which …

Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and
more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and …

An increased intestinal permeability has been described in various gastrointestinal and non-
gastrointestinal disorders. Nevertheless, the concept and definition of intestinal permeability …

The emerging evidence on the interconnectedness between the gut microbiome and host
metabolism has led to a paradigm shift in the study of metabolic diseases such as obesity …

Nonalcoholic fatty liver disease (NAFLD) is a chronic condition affecting one quarter of the
global population. Although primarily linked to obesity and metabolic syndrome …

НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ БОЛЕЗНЬ ПЕЧЕНИ У ВЗРОСЛЫХ: КЛИНИКА,
ДИАГНОСТИКА, ЛЕЧЕНИЕ.РЕКОМЕНДАЦИИ ДЛЯ ТЕРАПЕВТОВ, ТРЕТЬЯ ВЕРСИЯ …

Small intestinal bacterial overgrowth (SIBO) is defined as an increase in the bacterial
content of the small intestine above normal values. The presence of SIBO is detected in …

The complex interplay between the gut microbiota, the intestinal barrier, the immune system
and the liver is strongly influenced by environmental and genetic factors that can disrupt the …

Non-alcoholic fatty liver disease (NAFLD) represents a predominant hepatopathy that is
rapidly becoming the most common cause of hepatocellular carcinoma worldwide. The …

Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …